【BIO-K】 Japan-USA-Asia's Challenges Towards Innovation

May 13[Wed]
10:00 - 12:00
Course Leader:
Ken-ichi Arai
Professor Emeritus,
The University of Tokyo/
Director, Chairman,
SBI Biotech Co., Ltd.
Sub-course Leader:
Toichi Takenaka
Chairman, Japan Health Sciences Foundation/
Former Chairman of the Board, Astellas Pharma Inc.

AMED: It's Mission and Perspectives

Makoto Suematsu
Japan Agency for Medical Research and Development (AMED)*/
Dean, Professor of Biochemistry,
Keio University School of Medicine
*As of Apr. 1, 2015

Japan Agency for Medical Research and Development(AMED) aims to accelerate the speech and efficiency of medical R&D for aiding patients over the world. The lecture will show AMED's mission and perspectives of the new Agency.

Microphysiological Systems:
Innovative Tools for Drug Development and Disease Modeling

Danilo A. Tagle
Associate Director for Special Initiatives,
National Center for Advancing Translational Sciences,
National Institutes of Health (NIH)

The goal of the NIH Microphysiological Systems program is to develop bio-engineered microdevices that represent functional units of the 10 major human organ systems: circulatory, respiratory, integumentary, reproductive, endocrine, gastrointestinal, nervous, urinary, musculoskeletal, and immune using hiPSCs. This unique and novel in vitro platform could help ensure that safe and effective therapeutics are identified sooner, and ineffective or toxic ones are rejected early in the drug development process. These microfabricated devices are also useful for modeling human diseases and may prove to be sufficient alternatives to the use of animal models.

Dr. Danilo Tagle is Associate Director for Special Initiatives at the National Center for Advancing Translational Sciences (NCATS). He leads and manages the 1) NIH Microphysiological Systems program, 2) Extracellular RNA Communication program, and 3) the Stimulating Peripheral Activity to Relive Conditions (SPARC) program. These multidisciplinary programs involve coordination of activities with other NIH institutes and centers, including the NIH Common Fund, as well as partnerships with other government agencies, such FDA and DARPA, and the private sector. In addition to being Associate Director for Special Initiatives, Dr. Tagle recently served as Acting Director for the NCATS Office of Grants Management and Scientific Review, and currently serves as Executive Secretary to the NCATS Advisory Council, as well as the Cures as well as the Cures Acceleration Network Review Board.

Malaysia's Challenge in Becoming an Industrial State in Biotechnology

The Government of Malaysia

To be updated soon.

To be updated soon.